Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2010 /
Signalling pathways as a target for cancer therapies

7th - 10th Nov 2010

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.02.11
Views: 8236

Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK

A number of signalling pathways discovered in Drosophila flies and other model organisms have subsequently turned out to be important in cancer and specifically in cancer stem cell function. Prof Mariann Bienz talks about the role of the Wnt signalling pathway in cancer growth and cancer metastases but warns of difficulties developing therapies to target this pathway. Prof Bienz explains what progress has been made by academic labs working to develop therapies to target signalling pathways and explains the mechanisms through which the pathways can be affected.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation